NU Skin Enterprises, Inc. balance sheet

At the end of fiscal 2025, NU Skin Enterprises, Inc. had total assets of $1.41bn, total liabilities of $600m and shareholders' equity of $805m. It held $239m in cash against $225m of debt: net cash of $13.6m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

NU Skin Enterprises, Inc.: balance sheet, annual
Fiscal year	2009Dec 2009	2010Dec 2010	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash and equivalents	158	230	273	320	525	288	289	357	426	387	336	403	340	265	256	187	239	190
Receivables	—	—	—	—	—	—	—	—	—	—	50	63	41	47	59	51	40	49
Inventory	106	114	112	136	340	338	265	250	253	296	276	314	400	346	280	190	179	191
Total current assets	338	423	530	589	1,118	835	706	714	778	799	740	903	873	760	702	539	548	508
Goodwill	112	112	112	112	112	112	112	115	115	197	197	203	206	206	218	84	84	5
Total assets	748	892	991	1,125	1,821	1,614	1,506	1,474	1,590	1,694	1,769	1,957	1,906	1,821	1,809	1,469	1,405	1,122
Accounts payable	25	25	32	48	83	35	29	41	50	48	39	66	50	54	43	35	26	38
Deferred revenue (current)	—	—	—	—	—	—	7	13	15	14	13	18	22	19	13	8	7	6
Total current liabilities	185	216	241	320	777	418	408	399	447	440	357	543	530	359	329	297	264	256
Short-term debt	35	28	29	39	68	83	68	83	78	69	28	30	108	25	25	30	20	20
Long-term debt	121	133	108	155	114	165	182	334	311	361	334	305	269	377	478	364	204	194
Total debt	157	161	137	194	182	253	254	435	402	434	365	338	376	402	505	395	225	214
Total liabilities	373	421	417	534	962	672	680	810	885	913	894	1,063	994	924	987	817	600	579
Shareholders' equity	376	471	574	591	859	942	826	664	705	782	875	894	913	897	822	651	805	543
Net debt (negative = net cash)	−2	−69	−136	−126	−343	−36	−35	78	−25	48	29	−65	37	138	249	208	−14	24

US$ millions unless shown otherwise. Fiscal quarters.

NU Skin Enterprises, Inc.: balance sheet, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Receivables	69	51	57	60	49	40	45	49
Inventory	248	190	189	180	179	179	179	191
Total current assets	653	539	525	572	548	548	523	508
Goodwill	100	84	84	84	84	84	84	5
Total assets	1,583	1,469	1,391	1,444	1,424	1,405	1,377	1,122
Accounts payable	33	35	34	29	29	26	29	38
Deferred revenue (current)	12	8	8	7	7	7	6	6
Total current liabilities	339	297	260	284	254	264	257	256
Short-term debt	60	30	20	35	20	20	20	20
Long-term debt	373	364	219	214	209	204	204	194
Total debt	433	394	239	249	229	224	224	214
Total liabilities	876	817	637	656	625	600	583	579
Shareholders' equity	707	651	754	788	800	805	794	543

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: IPAR vs NUS ELF vs NUS NUS vs USNA NUS vs ODD

More: Personal Care Products stocks compared, Consumer Staples sector, rankings of US companies

Figures from NU Skin Enterprises, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to NU Skin Enterprises, Inc.